Next earnings date: 22 Aug 2025
Biofrontera AG – LSE:0DOL.L
Biofrontera AG stock price today
Biofrontera AG stock price monthly change
Biofrontera AG stock price quarterly change
Biofrontera AG stock price yearly change
Biofrontera AG key metrics
Market Cap | 52.24M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.20 |
Revenue | 32.24M |
EBITDA | 5.12M |
Income | -369K |
Revenue Q/Q | 94.51% |
Revenue Y/Y | 25.29% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 15.88% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiofrontera AG stock price history
Biofrontera AG stock forecast
Biofrontera AG financial statements
| Mar 2023 | 5.79M | -3.47M | -59.92% |
|---|---|---|---|
| Jun 2023 | 11.98M | 330K | 2.75% |
| Sep 2023 | 7.01M | -3.14M | -44.78% |
| Dec 2023 | 7.45M | 5.91M | 79.42% |
| Mar 2023 | 26904000 | 10.03M | 37.29% |
|---|---|---|---|
| Jun 2023 | 27571000 | 10.50M | 38.11% |
| Sep 2023 | 24019000 | 10.13M | 42.18% |
| Dec 2023 | 30732000 | 10.75M | 34.99% |
| Mar 2023 | 0 | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 0 | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
Biofrontera AG alternative data
| Aug 2023 | 108 |
|---|---|
| Sep 2023 | 108 |
| Oct 2023 | 108 |
| Nov 2023 | 108 |
| Dec 2023 | 91 |
| Jan 2024 | 91 |
| Feb 2024 | 91 |
| Mar 2024 | 91 |
| Apr 2024 | 91 |
| May 2024 | 91 |
| Jun 2024 | 95 |
| Jul 2024 | 97 |
Biofrontera AG other data
| Insider | Compensation |
|---|---|
Dr. Hermann Lübbert (1956) Co-Founder, Chairman of the Executive Board & Chief Executive Officer | $681,920 |
Mr. Thomas Schaffer (1963) Chief Financial Officer & Member of the Executive Board | $422,680 |
Pamela Keck Head of Investor Relations | |
Mr. Alexander Richardson Head of UK Sales Team | |
Dr. Matthias Naumann Head of Sales & Marketing - Europe |
-
What's the price of Biofrontera AG stock today?
One share of Biofrontera AG stock can currently be purchased for approximately $2.39.
-
When is Biofrontera AG's next earnings date?
Biofrontera AG is estimated to report earnings on Friday, 22 Aug 2025.
-
Does Biofrontera AG pay dividends?
No, Biofrontera AG does not pay dividends.
-
How much money does Biofrontera AG make?
Biofrontera AG has a market capitalization of 52.24M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25.3% to 32.25M US dollars.
-
What is Biofrontera AG's stock symbol?
Biofrontera AG is traded on the LSE under the ticker symbol "0DOL.L".
-
What is Biofrontera AG's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Biofrontera AG?
Shares of Biofrontera AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Biofrontera AG's key executives?
Biofrontera AG's management team includes the following people:
- Dr. Hermann Lübbert Co-Founder, Chairman of the Executive Board & Chief Executive Officer(age: 69, pay: $681,920)
- Mr. Thomas Schaffer Chief Financial Officer & Member of the Executive Board(age: 62, pay: $422,680)
- Pamela Keck Head of Investor Relations
- Mr. Alexander Richardson Head of UK Sales Team
- Dr. Matthias Naumann Head of Sales & Marketing - Europe
-
Is Biofrontera AG founder-led company?
Yes, Biofrontera AG is a company led by its founder Dr. Hermann Lübbert.
-
How many employees does Biofrontera AG have?
As Jul 2024, Biofrontera AG employs 97 workers, which is 2% more then previous month and 7% more then previous quarter.
-
When Biofrontera AG went public?
Biofrontera AG is publicly traded company for more then 2 years since IPO on 21 Apr 2023.
-
What is Biofrontera AG's official website?
The official website for Biofrontera AG is biofrontera.com.
-
How can i contact Biofrontera AG?
Biofrontera AG can be reached via phone at +49 214 876320.
Biofrontera AG company profile:
Biofrontera AG
biofrontera.comLSE
79
Medical - Pharmaceuticals
Healthcare
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
Leverkusen, 51377
:
:
:
